Empower Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
1,239
+2
+0.2% +$416 ﹤0.01% 443
2026
Q1
$261K Sell
1,237
-229
-16% -$49.3K ﹤0.01% 441
2025
Q4
$301K Sell
1,466
-559
-28% -$105K ﹤0.01% 413
2025
Q3
$318K Buy
2,025
+10
+0.5% +$1.54K ﹤0.01% 420
2025
Q2
$339K Sell
2,015
-138
-6% -$20.5K ﹤0.01% 383
2025
Q1
$297K Buy
2,153
+141
+7% +$18K ﹤0.01% 401
2024
Q4
$238K Sell
2,012
-22
-1% -$2.57K ﹤0.01% 453
2024
Q3
$225K Sell
2,034
-17
-0.8% -$1.78K ﹤0.01% 457
2024
Q2
$202K Sell
2,051
-845
-29% -$86.1K ﹤0.01% 481
2024
Q1
$324K Buy
2,896
+469
+19% +$50.6K ﹤0.01% 388
2023
Q4
$245K Buy
2,427
+26
+1% +$2.58K ﹤0.01% 429
2023
Q3
$208K Buy
2,401
+19
+0.8% +$1.72K ﹤0.01% 440
2023
Q2
$225K Buy
+2,382
New +$201K ﹤0.01% 450

Other funds holding CAH

Empower Advisory Group's CAH Position: Q2 2026 in Review

Empower Advisory Group increased its Cardinal Health (CAH) stake by 0.16% in Q2 2026, buying an estimated $416 and bringing the position to 1,239 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Empower Advisory Group first reported a position in CAH in Q2 2023 and has held it in 13 quarters since. The position peaked at $339K in Q2 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Empower Advisory Group held 1,239 shares of Cardinal Health worth $294K as of Q2 2026.
  • Empower Advisory Group bought 2 Cardinal Health shares in Q2 2026, an estimated $416.
  • Cardinal Health made up ﹤0.01% of Empower Advisory Group's portfolio in Q2 2026, its #443 holding.
  • Empower Advisory Group first reported a position in Cardinal Health in Q2 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Cardinal Health position peaked at $339K in Q2 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.